“…A.C.T.H. produces many of the effects seen in the pseudodiabetic patient: eosinopenia (Wight et al, 1953), raised plasma level of 17-hydroxycorticosteroids (Hume and Wittenstein, 1950), increased urinary potassium loss (Prunty, 1950), increased urinary 17-ketosteroids (Evans and Butterfield, 1951), and depletion of adrenal cortical lipoid (Symington and Davidson, 1956).…”